Vogt-Koyanagi-Harada disease presenting secondary to a post-infectious Mycoplasma pneumoniae autoimmune response

Christian I Wade1, Keith E Earley2, Grant A Justin3,4

  • 1School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.

Abstract

Insights

A rare case of Vogt-Koyanagi-Harada disease was linked to Mycoplasma pneumoniae infection. Prompt steroid treatment restored vision in a young patient, highlighting the autoimmune connection.

Area of Science:

  • Ophthalmology
  • Infectious Disease
  • Immunology

Background:

  • Vogt-Koyanagi-Harada (VKH) disease is a rare, idiopathic multisystem inflammatory disorder.
  • Ocular manifestations of VKH disease can lead to significant visual impairment.

Observation:

  • A 14-year-old Hispanic female presented with decreased visual acuity, bilateral hyperemia, subretinal fluid, and vitreous cells.
  • Diagnostic imaging revealed characteristic findings of VKH disease.
  • Laboratory tests indicated elevated Mycoplasma pneumoniae IgM and rising IgG antibodies.

Findings:

  • The patient's clinical presentation and serological results strongly suggested a diagnosis of VKH disease secondary to Mycoplasma pneumoniae infection.
  • Ocular inflammation, including decreased visual acuity, was effectively managed with topical and oral corticosteroids.

Implications:

  • This case highlights a potential autoimmune response to Mycoplasma pneumoniae triggering VKH disease.
  • Early diagnosis and appropriate corticosteroid therapy are crucial for managing ocular manifestations and preserving vision.

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.3K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.5K
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
253
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
1.3K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.0K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K